Bank of New York Mellon’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.62M | Buy |
|
|||||
|
2025
Q2 | $4.21M | Sell |
|
|||||
|
2025
Q1 | $7.2M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Sell |
|
|||||
|
2024
Q3 | $9.91M | Sell |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $19M | Sell |
|
|||||
|
2023
Q4 | $22.3M | Buy |
|
|||||
|
2023
Q3 | $13.7M | Buy |
|
|||||
|
2023
Q2 | $32.5M | Sell |
|
|||||
|
2023
Q1 | $25.9M | Sell |
|
|||||
|
2022
Q4 | $20.9M | Sell |
|
|||||
|
2022
Q3 | $27.9M | Buy |
|
|||||
|
2022
Q2 | $15.7M | Buy |
|
|||||
|
2022
Q1 | $16M | Buy |
|
|||||
|
2021
Q4 | $14.1M | Buy |
|
|||||
|
2021
Q3 | $8.88M | Buy |
|
|||||
|
2021
Q2 | $16.6M | Buy |
|
|||||
|
2021
Q1 | $9.75M | Sell |
|
|||||
|
2020
Q4 | $14.5M | Buy |
|
|||||
|
2020
Q3 | $7.19M | Sell |
|
|||||
|
2020
Q2 | $7.96M | Buy |
|
|||||
|
2020
Q1 | $6.43M | Buy |
|
|||||
|
2019
Q4 | $6.01M | Buy |
|
|||||
|
2019
Q3 | $4.58M | Sell |
|
|||||
|
2019
Q2 | $5.07M | Buy |
|
|||||
|
2019
Q1 | $3.31M | Buy |
|
|||||
|
2018
Q4 | $2.02M | Buy |
|
|||||
|
2018
Q3 | $2.54M | Buy |
|
|||||
|
2018
Q2 | $2.8M | Buy |
|
|||||
|
2018
Q1 | $771K | Buy |
|
|||||
|
2017
Q4 | $416K | Buy |
|